http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0187450-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
filingDate 1985-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3ac90e282ff94c2d1f4c3043213627b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d935b21732a8e6c448b230f8ab40c13
publicationDate 1986-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0187450-A2
titleOfInvention Process for the preparation of crystalline ceftazidime pentahydrate
abstract a Ceftazidime pentahydrate is obtained in purified crystalline form in a process comprising acidification of an aqueous solution of ceftazidime to about the optimum pH for nucleation of between about 4.0 and about 4.7 and maintenance at the optimum pH during crystallization. The crystalline product obtained exhibits enhanced stability toward polymer formation when stressed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0267427-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4954624-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8802752-A1
priorityDate 1984-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2466467-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451609951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128850235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5484131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422792
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426098768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5481173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18366337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451214182

Total number of triples: 48.